Association Between Human Pain-Related Genotypes and Variability in Opioid Analgesia: An Updated Review (Q38247246)

1 September 2017

1 reference

title

Association Between Human Pain-Related Genotypes and Variability in Opioid Analgesia: An Updated Review (English)

1 reference

1 September 2017

author

Lona Louring Christrup

Lona L Christrup

4

0 references

Anne Estrup Olesen

Anne E Olesen

2

0 references

Asbjørn Mohr Drewes

Asbjørn M Drewes

6

0 references

Lecia M Nielsen

1

Lecia M Nielsen

1 reference

1 September 2017

5

Hiroe Sato

1 reference

1 September 2017

Ruth Branford

3

1 reference

1 September 2017

publication date

9 September 2014

1 reference

1 September 2017

1 reference

1 September 2017

volume

15

1 reference

1 September 2017

issue

6

1 reference

1 September 2017

page(s)

580-594

1 reference

Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment

1 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

The Prevalence of Chronic Pain in United States Adults: Results of an Internet-Based Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

Pain management: a fundamental human right

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

Pharmacokinetic/pharmacodynamic relationships of transdermal buprenorphine and fentanyl in experimental human pain models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

Assessing analgesic actions of opioids by experimental pain models in healthy volunteers - an updated review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

Relationships between measurement of pain using visual analog score and morphine requirements during postoperative intravenous morphine titration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

Women Experience More Pain and Require More Morphine Than Men to Achieve a Similar Degree of Analgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

Human opioid receptor A118G polymorphism affects intravenous patient-controlled analgesia morphine consumption after total abdominal hysterectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

Comparable analgesic efficacy of transdermal buprenorphine in patients over and under 65 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

Ethnocultural influences on variation in chronic pain perception

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

Clinical pharmacology and pharmacotherapy of opioid switching in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

The polymorphism A118G of the human mu-opioid receptor gene decreases the pupil constrictory effect of morphine-6-glucuronide but not that of morphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

Exploring joint effects of genes and the clinical efficacy of morphine for cancer pain: OPRM1 and COMT gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

The pharmacogenetics of analgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

The ABCs of drug transport in intestine and liver: efflux proteins limiting drug absorption and bioavailability

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

Pharmacogenetics of opioids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

Transporters as a determinant of drug clearance and tissue distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

Role of pharmacogenetics of ATP-binding cassette transporters in the pharmacokinetics of drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

Effect of P-glycoprotein modulation on the clinical pharmacokinetics and adverse effects of morphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

Quinidine as a probe for the role of p-glycoprotein in the intestinal absorption and clinical effects of fentanyl

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

The effect of quinidine, used as a probe for the involvement of P-glycoprotein, on the intestinal absorption and pharmacodynamics of methadone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

Relationship between the C3435T and G2677T(A) polymorphisms in the ABCB1 gene and P-glycoprotein expression in human liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

Implications of genetic polymorphisms in drug transporters for pharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

Genetic predictors of the clinical response to opioid analgesics: clinical utility and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

The antinociceptive effect and adverse drug reactions of oxycodone in human experimental pain in relation to genetic variations in the OPRM1 and ABCB1 genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

Effects of genetic polymorphisms of OPRM1, ABCB1, CYP3A4/5 on postoperative fentanyl consumption in Korean gynecologic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

Association of ABCB1/MDR1 and OPRM1 gene polymorphisms with morphine pain relief.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

Cross-sectional analysis of the influence of currently known pharmacogenetic modulators on opioid therapy in outpatient pain centers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

Influence from genetic variability on opioid use for cancer pain: a European genetic association study of 2294 cancer pain patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

ABCB1 genetic variability and methadone dosage requirements in opioid-dependent individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

Impact of genetic polymorphisms in ABCB1, CYP2B6, OPRM1, ANKK1 and DRD2 genes on methadone therapy in Han Chinese patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

Contribution of cytochrome P450 and ABCB1 genetic variability on methadone pharmacokinetics, dose requirements, and response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

Differences between opioids: pharmacological, experimental, clinical and economical perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

Polymorphic human cytochrome P450 enzymes: an opportunity for individualized drug treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

CYP3A4*1G genetic polymorphism influences CYP3A activity and response to fentanyl in Chinese gynecologic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

The hypoalgesic effect of oxycodone in human experimental pain models in relation to the CYP2D6 oxidation polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

The analgesic effect of tramadol after intravenous injection in healthy volunteers in relation to CYP2D6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

Patient-controlled analgesia (PCA) with codeine for postoperative pain relief in ten extensive metabolisers and one poor metaboliser of dextromethorphan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

The impact of CYP2D6 genetic polymorphisms on postoperative morphine consumption.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

Pharmacogenetics of codeine metabolism in an urban population of children and its implications for analgesic reliability

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

Impact of the CYP2D6 genotype on post-operative intravenous oxycodone analgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

Impact of CYP2D6 genotype on postoperative tramadol analgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

Effect of the CYP2D6*10 C188T polymorphism on postoperative tramadol analgesia in a Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

Do CYP2D6 genotypes reflect oxycodone requirements for cancer patients treated for cancer pain? A cross-sectional multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

Effect of CYP3A4*1G on the fentanyl consumption for intravenous patient-controlled analgesia after total abdominal hysterectomy in Chinese Han population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

Impact of CYP3A4*1G polymorphism on metabolism of fentanyl in Chinese patients undergoing lower abdominal surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

Cytochrome P450 3A4 genetic polymorphisms and post-operative fentanyl requirements

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

A common human micro-opioid receptor genetic variant diminishes the receptor signaling efficacy in brain regions processing the sensory information of pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

Observational study of the effect of mu-opioid receptor genetic polymorphism on intrathecal opioid labor analgesia and post-cesarean delivery analgesia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

Genetic variability of the mu-opioid receptor influences intrathecal fentanyl analgesia requirements in laboring women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

The mu-opioid receptor gene polymorphism 118A>G depletes alfentanil-induced analgesia and protects against respiratory depression in homozygous carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

Pharmacokinetic-pharmacodynamic modeling of morphine-6-glucuronide-induced analgesia in healthy volunteers: absence of sex differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

Polymorphism of mu-opioid receptor gene (OPRM1:c.118A>G) does not protect against opioid-induced respiratory depression despite reduced analgesic response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

Ethnicity and OPRM variant independently predict pain perception and patient-controlled analgesia usage for post-operative pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

A118G single nucleotide polymorphism of human mu-opioid receptor gene influences pain perception and patient-controlled intravenous morphine consumption after intrathecal morphine for postcesarean analgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

Influence of mu-opioid receptor variant on morphine use and self-rated pain following abdominal hysterectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

A genetic association study of the functional A118G polymorphism of the human mu-opioid receptor gene in patients with acute and chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

Combined catechol-O-methyltransferase and mu-opioid receptor gene polymorphisms affect morphine postoperative analgesia and central side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

Association of mu-opioid receptor gene polymorphism (A118G) with variations in morphine consumption for analgesia after total knee arthroplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

Polymorphism of the micro-opioid receptor gene (OPRM1 118A>G) affects fentanyl-induced analgesia during anesthesia and recovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

Association between OPRM1 gene polymorphisms and fentanyl sensitivity in patients undergoing painful cosmetic surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

Association of human micro-opioid receptor gene polymorphism A118G with fentanyl analgesia consumption in Chinese gynaecological patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

Mu-opioid receptor (A118G) single-nucleotide polymorphism affects alfentanil requirements for extracorporeal shock wave lithotripsy: a pharmacokinetic-pharmacodynamic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

The associations between OPRM 1 and COMT genotypes and postoperative pain, opioid use, and opioid-induced sedation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

Diversity of opioid requirements for postoperative pain control following oral surgery--is it affected by polymorphism of the μ-opioid receptor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

Effect of μ-opioid receptor A118G polymorphism on the ED50 of epidural sufentanil for labor analgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

Analgesic requirements after major abdominal surgery are associated with OPRM1 gene polymorphism genotype and haplotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

The 118 A > G polymorphism in the human mu-opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

Human mu-opioid receptor gene A118G polymorphism predicts the efficacy of tramadol/acetaminophen combination tablets (ultracet) in oxaliplatin-induced painful neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

Analgesia and central side-effects: two separate dimensions of morphine response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

Genetic variation and response to morphine in cancer patients: catechol-O-methyltransferase and multidrug resistance-1 gene polymorphisms are associated with central side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

Increased sensitivity to thermal pain following a single opiate dose is influenced by the COMT val(158)met polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

Effect of catechol-o-methyltransferase-gene (COMT) variants on experimental and acute postoperative pain in 1,000 women undergoing surgery for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

The Val158Met polymorphism of the human catechol-O-methyltransferase (COMT) gene may influence morphine requirements in cancer pain patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

Genetic variation in the catechol-O-methyltransferase (COMT) gene and morphine requirements in cancer patients with pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

Individual differences in pain sensitivity: genetic and environmental contributions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

Functional genomics of pain in analgesic drug development and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

Gender differences in pain ratings and pupil reactions to painful pressure stimuli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

Gender role expectations of pain: relationship to experimental pain perception

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

Profound changes in drug metabolism enzymes and possible effects on drug therapy in neonates and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

Opioid genetics: the key to personalized pain control?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

The analgesic effect of pregabalin in patients with chronic pain is reflected by changes in pharmaco-EEG spectral indices

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

Environmental and genetic factors associated with morphine response in the postoperative period

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12232

21 January 2018

Identifiers

DOI

10.1111/PAPR.12232

1 reference

1 September 2017

1 reference